Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
The uptake of alternative biologics such as Roche/Chugai’s Actemra/RoActemra will erode the market share of TNF-alpha inhibitors over the next decade ...Learn More
Live on August 11, 2010 ...Learn More
See which reports have been searched on the most.
Donny Wong, Ph.D. August 3, 2010 10 a.m. ET, 4 p.m. CET
In this presentation, Dr. Wong will discuss the implications of an FDA panel’s vote against the approval of Vivus’s Qnexa as a weight loss agent ... Learn more
July 29, 2010
Sales of Drugs from Multinational Corporations Will Represent 92 Percent of Mexico’s Non-Small-Cell Lung Cancer Drug Market in 2014
July 28, 2010
In the Rheumatoid Arthritis Drug Market, the Uptake of Alternative Biologics Such as Roche/Chugai’s Actemra/RoActemra Will Erode the Market Share of TNF-Alpha Inhibitors Through 2019
July 21, 2010
Nearly Half of Surveyed US Payers Agree that Pharmacy-level Substitution of Biosimilars Is a Good Idea
Treatment Algorithms in Generalized Anxiety Disorder
Although there are more than 6 million prevalent cases of generalized anxiety disorder (GAD) in the United States... Read More
Treatment Algorithms in Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory disease of the large intestine and the rectum. The safety profile... Read More
Gastric Cancer (Event Driven)
Last Updated 29 July 2010Gastric cancer (GC) is the fourth-most common malignancy in terms of incidence and... Read More